Brazil Lab Targets Year-End Debut

Brazilian diagnostics laboratory company Fleury has unveiled key details of its plan to issue shares through an IPO, which is very likely going to be this year’s last initial offering. The deal will include a sale of 34.3m units at BRL15.00-BRL17.00. It will also involve a greenshoe of up to 5.1m shares. At the BRL16.00 midpoint, the deal could raise BRL630m. Pricing is scheduled for December 15, the tail end of the pre-holiday issuance season. Bradesco BBI is leading, with Morgan Stanley and JPMorgan as co-leads.